Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Rosutyle Gold 20-150 Tablet is a triple-combination cardiovascular medication used for the secondary prevention of atherosclerotic cardiovascular events such as heart attacks and strokes. It contains Rosuvastatin, a potent statin that lowers LDL cholesterol and triglycerides while raising HDL levels; Aspirin, an antiplatelet agent that prevents the formation of blood clots by inhibiting cyclooxygenase; and Clopidogrel, a P2Y12 inhibitor that further blocks platelet aggregation by targeting ADP receptors. This combination therapy provides comprehensive protection by targeting lipid levels and platelet activity, making it ideal for patients with existing cardiovascular conditions or those at high risk. Rosutyle Gold 20-150 helps reduce the likelihood of future cardiovascular events in patients with coronary artery disease, post-myocardial infarction, post-stenting, or with established atherosclerosis.
Common side effects may include muscle pain, abdominal discomfort, heartburn, headache, and increased bleeding tendency. Aspirin may cause gastritis or gastrointestinal ulcers, while Clopidogrel may lead to easy bruising or nosebleeds. Rosuvastatin, though generally well tolerated, may cause elevated liver enzymes or muscle-related symptoms like myopathy or rarely, rhabdomyolysis. Regular monitoring of liver function and lipid levels is advised, along with periodic assessment of bleeding risk.
Rosutyle Gold 20-150 Tablet is indicated for the secondary prevention of cardiovascular events such as myocardial infarction, stroke, and peripheral arterial disease. It is commonly prescribed to patients with a history of acute coronary syndrome, stent placement, coronary artery disease, or other high-risk cardiovascular conditions.
Rosutyle Gold 20-150 Tablet should be taken under medical supervision. It should not be used in patients with active bleeding, peptic ulcer disease, liver dysfunction, or hypersensitivity to any of its components. Caution is advised in patients with a history of stroke or bleeding disorders. The combination increases bleeding risk, especially when used with other anticoagulants or NSAIDs. Alcohol intake should be limited, and muscle-related symptoms should be reported immediately. This medication is not recommended during pregnancy or breastfeeding. Regular medical follow-up is important to ensure safety and therapeutic efficacy.
Store Rosutyle Gold 20-150 Tablet in a cool, dry place below 30°C. Protect from light and moisture. Keep the medication in its original packaging and out of reach of children. Do not use after the expiry date.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10 mg fenofibrate tablet
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet